|
⚲
|
| Keyboard |
| Rubin Steven D
✚
|
|
|---|---|
| CIK # | 0001381874 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001381874] | |
| 4 | [0001381874] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Entera Bio Ltd [ENTX]
Ordinary Shares, par value NIS 0.0000769 per share
|
2026-02-12 | Buy | 5,000 | $1.49 | 7,450 |
|
Entera Bio Ltd [ENTX]
Ordinary Shares, par value NIS 0.0000769 per share
|
2026-02-09 | Buy | 10,000 | $1.20 | 12,000 |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2026-01-09 | Grant | 16,410 | $0.00 | |
|
Red Violet Inc RDVT
Common Stock
|
2025-12-19 | Grant | 4,450 | ||
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
OPKO Health Inc OPK
Stock Option (Right to Buy) · derivative
|
2025-05-27 | Grant | 437,500 | $0.00 | |
|
Red Violet Inc RDVT
Common Stock
|
2025-03-19 | Sell | 10,000 | $38.93 | 389,300 |
|
Senesco Technologies Inc ELOX
Common Stock
|
2025-01-24 | Option exercise | 3,750 | $0.00 | |
|
Senesco Technologies Inc ELOX
Restricted Stock Units · derivative
|
2025-01-24 | Option exercise | 3,750 | $0.00 | |
|
Red Violet Inc RDVT
Common Stock
|
2024-11-04 | Grant | 8,000 | ||
|
Senesco Technologies Inc ELOX
Common Stock
|
2024-10-16 | Grant | 12,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2024-10-09 | Grant | 18,957 | ||
|
OPKO Health Inc OPK
Common Stock
|
2024-07-24 | Grant | 437,500 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Stock Option (right to buy) · derivative
|
2024-06-20 | Grant | 20,000 | $0.00 | |
|
Senesco Technologies Inc ELOX
Restricted Stock Units · derivative
|
2024-01-24 | Grant | 7,500 | $0.00 | |
|
OPKO Health Inc OPK
Common Stock
|
2024-01-05 | Buy | 10,000 | $0.87 | 8,700 |
|
Red Violet Inc RDVT
Common Stock
|
2023-11-30 | Grant | 10,800 | ||
|
OPKO Health Inc OPK
Common Stock
|
2023-11-10 | Buy | 10,000 | $1.30 | 13,000 |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2023-07-18 | Grant | 17,233 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Stock Option (right to buy) · derivative
|
2023-06-15 | Grant | 20,000 | $0.00 | |
| showing 20 of 175 most recent transactions | |||||